↓ Skip to main content

American Association for Cancer Research

CD20-Targeted Therapy Ablates De Novo Antibody Response to Vaccination but Spares Pre-Established Immunity

Overview of attention for article published in Blood Cancer Discovery, March 2022
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#21 of 207)
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news
1 news outlet
twitter
107 X users

Citations

dimensions_citation
38 Dimensions

Readers on

mendeley
27 Mendeley
Title
CD20-Targeted Therapy Ablates De Novo Antibody Response to Vaccination but Spares Pre-Established Immunity
Published in
Blood Cancer Discovery, March 2022
DOI 10.1158/2643-3230.bcd-21-0222
Pubmed ID
Authors

Tanaya Shree, Vishnu Shankar, Julian J K Lohmeyer, Debra K Czerwinski, Joseph G Schroers-Martin, Gladys M Rodriguez, Sara Beygi, Alyssa M Kanegai, Karen S Corbelli, Etelka Gabriel, David M Kurtz, Michael S Khodadoust, Neel K Gupta, Lauren S Maeda, Ranjana H Advani, Ash A Alizadeh, Ronald Levy

X Demographics

X Demographics

The data shown below were collected from the profiles of 107 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 27 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 15%
Researcher 4 15%
Student > Master 4 15%
Other 3 11%
Student > Postgraduate 3 11%
Other 3 11%
Unknown 6 22%
Readers by discipline Count As %
Medicine and Dentistry 13 48%
Biochemistry, Genetics and Molecular Biology 2 7%
Engineering 2 7%
Agricultural and Biological Sciences 1 4%
Unspecified 1 4%
Other 2 7%
Unknown 6 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 72. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 October 2022.
All research outputs
#592,602
of 25,413,176 outputs
Outputs from Blood Cancer Discovery
#21
of 207 outputs
Outputs of similar age
#15,927
of 448,517 outputs
Outputs of similar age from Blood Cancer Discovery
#3
of 18 outputs
Altmetric has tracked 25,413,176 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 207 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.8. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,517 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.